Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2020 08:30 ET | Source: Optinose, Inc.

Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

YARDLEY, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
June 19, 2020 10:00 ET | Source: Optinose, Inc.

Optinose Named a 2020 Best Place to Work by Philadelphia Business Journal

YARDLEY, Pa., June 19, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
May 27, 2020 16:30 ET | Source: Optinose, Inc.

Optinose to Host its Annual Meeting of Stockholders in Virtual Format

YARDLEY, Pa., May 27, 2020 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN) today announced that due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and...
May 26, 2020 09:00 ET | Source: Optinose, Inc.

Optinose to Present at the 2020 Jefferies Virtual Healthcare Conference

YARDLEY, Penn., May 26, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
May 14, 2020 16:15 ET | Source: Optinose, Inc.

Optinose to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

YARDLEY, Pa., May 14, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
May 07, 2020 16:01 ET | Source: Optinose, Inc.

Optinose Reports First Quarter 2020 Financial Results and Operational Updates

Company reports first quarter 2020 XHANCE net revenue of $7.1 million First quarter 2020 XHANCE prescriptions increased 149% from first quarter 2019 Conference call and webcast to be held today at...
April 30, 2020 16:15 ET | Source: Optinose, Inc.

Optinose to Report First Quarter 2020 Financial Results and Corporate Updates on May 7, 2020

Conference Call and Webcast Scheduled for Thursday, May 7 at 4:15 p.m. Eastern Time YARDLEY, Pa., April 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on...
March 05, 2020 06:30 ET | Source: Optinose, Inc.

Optinose Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Operational Highlights

Company reports fourth quarter and full year 2019 XHANCE net revenue of $11.1 million and $30.4 million Fourth quarter 2019 XHANCE prescriptions increased 26% from third quarter 2019 Company expects...
February 27, 2020 16:30 ET | Source: Optinose, Inc.

Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020

YARDLEY, Pa., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
February 19, 2020 07:00 ET | Source: Optinose, Inc.

Optinose Appoints Victor Clavelli as Chief Commercial Officer

YARDLEY, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...